• Publications
  • Influence
Adjuvant therapy of pemphigus.
  • J. Bystryn
  • Medicine
  • Archives of dermatology
  • 1 July 1984
The effectiveness of adjuvant therapy of pemphigus was evaluated by comparing the results of studies of pemphigus treated with corticosteroids and adjuvant as opposed to corticosteroids only. ThereExpand
  • 216
  • 8
CDKN2A mutations in multiple primary melanomas.
  • J. Bystryn
  • Medicine
  • The New England journal of medicine
  • 1998
  • 71
  • 8
Patterns of remission in pemphigus vulgaris.
BACKGROUND The incidence of remissions in pemphigus is unclear because these are usually reported at a single point in the evolution of the disease. Thus it is uncertain whether treatment simplyExpand
  • 174
  • 6
Autoimmune diseases of the skin.
  • J. Bystryn
  • Medicine
  • Allergy proceedings : the official journal of…
  • 1 November 1989
The skin is the target of several autoimmune diseases which are directed to antigens which are normal components of the skin. These diseases can be differentiated according to the antigen which isExpand
  • 24
  • 4
Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity.
Human vitiligo is a common depigmenting disorder that is often associated with polyendocrinopathies. The etiology of vitiligo is unknown although there is indirect evidence of a strong associationExpand
  • 178
  • 3
Prognostic significance of hypopigmentation in malignant melanoma.
It has been suggested that the presence of cutaneous hypopigmentation favorably influences the prognosis of patients with malignant melanoma (MM). To examine this possibility, we have compared theExpand
  • 218
  • 3
Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma.
Current reports have suggested a role for intracellular adhesion molecule 1 (ICAM-1) in the progression of human malignant melanoma and other cancers. Stage I, II, and III patients withExpand
  • 179
  • 3
  • PDF
Correlation between vitiligo antibodies and extent of depigmentation in vitiligo.
We correlated the level of vitiligo antibodies to the extent of depigmentation in thirty-two patients with vitiligo. Vitiligo antibodies were assayed by protein A-sepharose immunoprecipitationExpand
  • 139
  • 3
Identification of pigment cell antigens defined by vitiligo antibodies.
Patients with vitiligo have circulating antibodies to pigment cells. To characterize this response further and to identify the antigens defined by vitiligo antibodies, sera of 23 patients withExpand
  • 99
  • 3
Immune mechanisms in vitiligo.
  • J. Bystryn
  • Medicine
  • Clinics in dermatology
  • 1 November 1997
V itiligo is a caused by cytes. As disfiguring disease of the skin that is the selective destruction of melanoa result, white patches of complete depigmentation appear on the skin. The disease isExpand
  • 52
  • 3